Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update
LONDON AND PHILADELPHIA, March 07, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing...
Cancer
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
First-ever HPV16-positive head and neck cancer Phase 3 clinical trialPRINCETON, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation...
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security SectorsWEXFORD, Pa., March 07, 2025 (GLOBE NEWSWIRE)...
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
Philadelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of...
mPATH Health Triumphs with Double Recognition for Excellence in Cancer Care
Winston-Salem-based Digital Health Company Receives Two Prestigious Awards at ViVE Event in Nashville, TN WINSTON-SALEM, N.C., March 6, 2025 /PRNewswire/...
Cure© Hosts Power of X Summit to Drive Investment and Solutions in Untapped Trillion-Dollar Market Addressing Health of Women
Event's Impact Challenge to Award One Early-Stage Company Up to $100K for Innovative Women's Health Solutions NEW YORK, March 6,...
Patriots Coach Vrabel and Celtics Coach Mazzulla to Join Granite’s ‘Saving by Shaving’ Event to Benefit Boston Children’s Hospital
12th Annual Event on March 11 Expected to Raise More Than $3.5 Million QUINCY, Mass., March 6, 2025 /PRNewswire/ -- Granite...
Ready® Recognized on Bain & Company’s 2025 Insurgent Brands List
Bain's list identifies the fast-moving consumer goods companies reshaping their categories PITTSBURGH, March 6, 2025 /PRNewswire/ -- Ready®, a functional...
FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program
Program supports women entrepreneurs in life science who are driving the advancement of innovations and healthcare TORONTO, March 6, 2025...
Covenant Health Fort Sanders Regional First in Tennessee to Bring Perimeter Medical Imaging AI’s Pioneering Technology to Surgery
TORONTO and DALLAS, March 6, 2025 /PRNewswire/ - In advance of International Women's Day, Perimeter Medical Imaging AI, Inc. (TSXV: PINK)...
Paradigm Health adds former US Secretary of Veterans Affairs, Dr. David Shulkin, to advisory board and ramps up AI-driven efforts to bring cancer clinical trials to rural America
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the...
HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,...
St. Baldrick’s Foundation Awards $1.4 Million in Fellowships to Advance Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - March 6, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
THE WOODLANDS, TX, March 06, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
March 6, 2025 Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025
SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Lisata Therapeutics to Present at the Investival Showcase USA
BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) PercentPhiladelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) -...
Pluto Health Now Qualified Under Medicaid Tennessee, Expanding Access to Essential Healthcare Services
DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Pluto Health, a Duke-University spin-out, is now a qualified Medicaid provider in TN. The...